ST 1103
Latest Information Update: 08 Aug 2007
Price :
$50 *
At a glance
- Originator sigma-tau SpA
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Mycoses
Most Recent Events
- 20 Jul 1998 No-Development-Reported for Bacterial infections in Italy (Unknown route)
- 20 Jul 1998 No-Development-Reported for Mycoses in Italy (Unknown route)
- 17 Jul 1995 New profile